Olası Trastuzumab Kullanımına Bağlı Gelişen Pyojenik Granülom
Son yıllarda, insan epidermal reseptörü HER ’nü hedefleyen ilaçlar solid tümörlerin tedavisinde başarılı bir şekilde kullanılmaya başlamıştır. HER 1 inhibitörlerine bağlı çok sayıda kutanöz yan etki bildirilmiş olmasına rağmen, HER 2 ile ilişkili spesifik kutanöz yan etki nadir olarak bildirilmiş...
Saved in:
| Main Authors: | Hilmi Cevdet Altınyazar, Özlem Bilgiç |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Selcuk University Press
2013-01-01
|
| Series: | Genel Tıp Dergisi |
| Subjects: | |
| Online Access: | https://dergipark.org.tr/tr/download/article-file/2156852 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Induction of SUSD2 by STAT3 Activation Is Associated with Tumor Recurrence in HER2-Positive Breast Cancer
by: Yisun Jeong, et al.
Published: (2024-12-01) -
Comparison of T-DM1 and trastuzumab-pertuzumab in HER2-positive breast cancer patients with residual disease after neoadjuvant therapy: a retrospective study
by: Junxiao Wang, et al.
Published: (2025-07-01) -
Detection of serum HER2 in patients treated with neratinib or trastuzumab: analysis of the I-SPY Trial
by: Mark Hensley, et al.
Published: (2025-07-01) -
Trastuzumab deruxtecan: A quantum leap in HER2-positive breast cancer
by: Manikandan Dhanushkodi
Published: (2019-01-01) -
Achievement of complete morphological regression in the use of trastuzumab in patients with inoperable locally advanced Her-2+ breast cancer
by: K. R. Zeinalova, et al.
Published: (2014-07-01)